Aller au contenu
BIOTHERAPEUTICS DEVELOPABILITY
AND RISK MITIGATION
Menu
Home
Agenda
Workshops
Sponsors & Exhibitors
Partners
Committees
Venue
BioprocessWatch
Register/B2B Access
SCIENTIFIC ADVISORY BOARD
Alain Beck
Senior Director, Biologics CMC & developability
Centre d'Immunologie Pierre Fabre
Roland Beliard
Business Development Director
LFB Biomanufacturing
Nicola Beltraminelli
Chief Development Officer
Innate Pharma
Hervé Broly
Executive CMC Consultant for Biologics
Merck
Cédric Charretier
Global Head Vaccine Drug Substance Development, Vaccine CMC Development Supply
Sanofi
Olivier Cochet
Head of Biotech Developpment and Supply
Debiopharm
Arnaud Delobel
R&D Director Strategy & Innovation
Quality Assistance
Sophie Derenne
Head of the Department Analysis and Market Development
Etablissement Français du Sang (EFS)
Annick Gervais
Head of Analytical Development Sciences
UCB Pharma
Michaël Lanero Fidalgo
Chief Operating Officer
TreeFrog Therapeutics
Oumeya (Mia) Adjali
Senior Scientist in Gene Therapy, Head of TaRGeT laboratory
INSERM
Nathalie Heuzé-Vourc'h
Research Professor Inserm, Deputy director "Health Technologies" Institute
INSERM
Miliza Diab
Upstream lab lead - MSAT
Novartis
John Churchwell
Associate Lead Scientist
Catapult
Guillaume Rousseau
MSAT Site lead
Sanofi Vitry